State-of-the-Art Lecture: Transplanting the Critically Ill Patient

For ILTS members only, please join now or renew your membership.

December 19, 2021

Sorry, you don't have access to this webinar!



  • Identify when and how the critically ill patients can undergo liver transplantation
  • Provide an overview of the modern role of the Liver Transplant Anesthesiologist in patient care from the time of selection to the time of transplantation
  • Understand the current state of liver support systems in managing critically ill patients with liver disease


  • Introduction of the State-of-the-Art-Lecture (Manhal Izzy)
  • Liver support systems: Where are we now? (Jean-Charles Duclos-Vallée)
  • Too sick for transplant? The Anesthesiologist’s role in candidates selection and transplantation (Annabel Blasi)
  • Q&A
  • Closing Remarks
Speaker Details

Jean-Charles Duclos-Vallée


Dr. Duclos-Vallée is a professor of Hepatology at the Centre Hépato-Biliaire, Paul-Brousse Hospital, Villejuif, France. He is the president of the French Institute of Biofabrication: and the coordinator of the University Hospital Federation “Hepatinov” which promotes innovative projects in Hepatology and more particularly in liver regenerative medicine: His areas of expertise are end stage liver disease, liver transplantation, rare liver disorders, and bioengineering

Annabel Blasi


Dr. Blasi is an Anesthesiology consultant in the liver transplant team at the Hospital Clinic in Barcelona. She is also a researcher at the University of California San Francisco (UCSF), and University Medical Centre Groninga (UMCG) laboratory. Her areas of interest are coagulation in liver disease and perioperative management of liver transplant candidates.

Manhal Izzy


Dr. Izzy is an Assistant Professor of Medicine and a Transplant Hepatology consultant at Vanderbilt University Medical Centre. He serves as the chair for the education and scholarship committee of ILTS and the co-chair/topic coordinator for the Cardiovascular Special Interest Group of ILTS. His main research interest is in clinical outcomes that relate to Cirrhotic Cardiomyopathy and cardiovascular disease in liver transplant candidates and recipients. He is one of the founding members for the Cirrhotic Cardiomyopathy Consortium that published the new diagnostic criteria for Cirrhotic Cardiomyopathy in 2020.

More from this meeting
More from these speakers